��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
永固-KY(5546)
月營收
季盈餘
2025/04/01
29.50元 (永固-KY股價)
2025/04/01
-2.45%
(年增率)
258百萬元 (營收)
永固-KY(5546) 年度營收走勢圖
永固-KY(5546)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/04
258,207
14.75%
264,705
-2.45%
789,348
-24.11%
114/03
225,012
79.84%
295,490
-23.85%
531,141
-31.50%
114/02
125,116
-30.88%
83,037
50.68%
306,129
-36.21%
114/01
181,013
-31.50%
396,866
-54.39%
181,013
-54.39%
113/12
264,241
9.46%
348,313
-24.14%
2,795,491
-26.39%
113/11
241,406
17.20%
358,274
-32.62%
2,531,250
-26.62%
113/10
205,981
13.63%
300,528
-31.46%
2,289,844
-25.92%
113/09
181,267
8.00%
330,708
-45.19%
2,083,863
-25.32%
113/08
167,835
-30.96%
327,007
-48.68%
1,902,596
-22.65%
113/07
243,093
30.63%
298,044
-18.44%
1,734,761
-18.66%
113/06
186,099
-29.90%
325,737
-42.87%
1,491,668
-18.70%
113/05
265,470
0.29%
374,032
-29.02%
1,305,569
-13.48%
113/04
264,705
-10.42%
340,655
-22.30%
1,040,098
-8.36%
113/03
295,490
255.85%
360,140
-17.95%
775,393
-2.38%
113/02
83,037
-79.08%
246,220
-66.28%
479,903
10.54%
113/01
396,866
13.94%
187,936
111.17%
396,866
111.17%
112/12
348,313
-2.78%
332,410
4.78%
3,797,594
-14.41%
112/11
358,274
19.21%
232,538
54.07%
3,449,281
-15.96%
112/10
300,528
-9.13%
431,338
-30.33%
3,091,007
-20.17%
112/09
330,708
1.13%
408,364
-19.02%
2,790,479
-18.90%
112/08
327,007
9.72%
336,943
-2.95%
2,459,771
-18.88%
112/07
298,044
-8.50%
396,731
-24.88%
2,132,763
-20.87%
112/06
325,737
-12.91%
381,383
-14.59%
1,834,719
-20.18%
112/05
374,032
9.80%
374,482
-0.12%
1,508,983
-21.29%
112/04
340,655
-5.41%
450,836
-24.44%
1,134,951
-26.43%
112/03
360,140
46.27%
456,405
-21.09%
794,296
-27.26%
112/02
246,220
31.01%
168,434
46.18%
434,156
-31.68%
112/01
187,936
-43.46%
467,054
-59.76%
187,936
-59.76%
111/12
332,410
42.95%
621,994
-46.56%
4,436,920
-24.97%
111/11
232,538
-46.09%
640,562
-63.70%
4,104,510
-22.44%
111/10
431,338
5.63%
678,097
-36.39%
3,871,971
-16.75%
111/09
408,364
21.20%
584,662
-30.15%
3,440,634
-13.40%
111/08
336,943
-15.07%
425,431
-20.80%
3,032,269
-10.51%
111/07
396,731
4.02%
450,572
-11.95%
2,695,326
-9.03%
111/06
381,383
1.84%
430,493
-11.41%
2,298,595
-8.50%
111/05
374,482
-16.94%
450,101
-16.80%
1,917,212
-7.90%
111/04
450,836
-1.22%
496,725
-9.24%
1,542,730
-5.45%
111/03
456,405
170.97%
1,091,894
111/02
168,434
-63.94%
635,488
111/01
467,054
-24.91%
467,054
110/12
621,994
-2.90%
5,913,704
110/11
640,562
-5.54%
5,291,709
110/10
678,097
15.98%
4,651,148
110/09
584,662
37.43%
3,973,051
110/08
425,431
-5.58%
3,388,389
110/07
450,572
4.66%
2,962,958
110/06
430,493
-4.36%
2,512,206
110/05
450,101
-9.39%
2,081,713
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
